129 related articles for article (PubMed ID: 2259254)
1. Modulation of ovariectomy-related bone loss by parathyroid hormone in rats.
Kalu DN; Echon R; Hollis BW
Mech Ageing Dev; 1990 Oct; 56(1):49-62. PubMed ID: 2259254
[TBL] [Abstract][Full Text] [Related]
2. Human parathyroid hormone-(1-34) prevents bone loss and augments bone formation in sexually mature ovariectomized rats.
Liu CC; Kalu DN
J Bone Miner Res; 1990 Sep; 5(9):973-82. PubMed ID: 2281827
[TBL] [Abstract][Full Text] [Related]
3. Preexisting bone loss associated with ovariectomy in rats is reversed by parathyroid hormone.
Liu CC; Kalu DN; Salerno E; Echon R; Hollis BW; Ray M
J Bone Miner Res; 1991 Oct; 6(10):1071-80. PubMed ID: 1796755
[TBL] [Abstract][Full Text] [Related]
4. Sequential treatment with basic fibroblast growth factor and PTH is more efficacious than treatment with PTH alone for increasing vertebral bone mass and strength in osteopenic ovariectomized rats.
Iwaniec UT; Mosekilde L; Mitova-Caneva NG; Thomsen JS; Wronski TJ
Endocrinology; 2002 Jul; 143(7):2515-26. PubMed ID: 12072383
[TBL] [Abstract][Full Text] [Related]
5. Programmed administration of parathyroid hormone increases bone formation and reduces bone loss in hindlimb-unloaded ovariectomized rats.
Turner RT; Evans GL; Cavolina JM; Halloran B; Morey-Holton E
Endocrinology; 1998 Oct; 139(10):4086-91. PubMed ID: 9751486
[TBL] [Abstract][Full Text] [Related]
6. A comparative study of the bone metabolic response to dried plum supplementation and PTH treatment in adult, osteopenic ovariectomized rat.
Smith BJ; Bu SY; Wang Y; Rendina E; Lim YF; Marlow D; Clarke SL; Cullen DM; Lucas EA
Bone; 2014 Jan; 58():151-9. PubMed ID: 24125756
[TBL] [Abstract][Full Text] [Related]
7. Skeletal effects of parathyroid hormone infusion in ovariectomized rats with or without estrogen repletion.
Shen V; Birchman R; Wu DD; Lindsay R
J Bone Miner Res; 2000 Apr; 15(4):740-6. PubMed ID: 10780865
[TBL] [Abstract][Full Text] [Related]
8. Differential transcriptional effects of PTH and estrogen during anabolic bone formation.
von Stechow D; Zurakowski D; Pettit AR; Müller R; Gronowicz G; Chorev M; Otu H; Libermann T; Alexander JM
J Cell Biochem; 2004 Oct; 93(3):476-90. PubMed ID: 15372627
[TBL] [Abstract][Full Text] [Related]
9. The aged rat model of ovarian hormone deficiency bone loss.
Kalu DN; Liu CC; Hardin RR; Hollis BW
Endocrinology; 1989 Jan; 124(1):7-16. PubMed ID: 2909382
[TBL] [Abstract][Full Text] [Related]
10. Sequential treatment with basic fibroblast growth factor and parathyroid hormone restores lost cancellous bone mass and strength in the proximal tibia of aged ovariectomized rats.
Wronski TJ; Ratkus AM; Thomsen JS; Vulcan Q; Mosekilde L
J Bone Miner Res; 2001 Aug; 16(8):1399-407. PubMed ID: 11499862
[TBL] [Abstract][Full Text] [Related]
11. Parathyroid hormone increases bone formation and improves mineral balance in vitamin D-deficient female rats.
Toromanoff A; Ammann P; Mosekilde L; Thomsen JS; Riond JL
Endocrinology; 1997 Jun; 138(6):2449-57. PubMed ID: 9165035
[TBL] [Abstract][Full Text] [Related]
12. Biosynthetic human parathyroid hormone (1-34) effects on bone quality in aged ovariectomized rats.
Sato M; Zeng GQ; Turner CH
Endocrinology; 1997 Oct; 138(10):4330-7. PubMed ID: 9322947
[TBL] [Abstract][Full Text] [Related]
13. Six-month daily administration of parathyroid hormone and parathyroid hormone-related protein peptides to adult ovariectomized rats markedly enhances bone mass and biomechanical properties: a comparison of human parathyroid hormone 1-34, parathyroid hormone-related protein 1-36, and SDZ-parathyroid hormone 893.
Stewart AF; Cain RL; Burr DB; Jacob D; Turner CH; Hock JM
J Bone Miner Res; 2000 Aug; 15(8):1517-25. PubMed ID: 10934650
[TBL] [Abstract][Full Text] [Related]
14. Effects of combined and separate intermittent administration of low-dose human parathyroid hormone fragment (1-34) and 17 beta-estradiol on bone histomorphometry in ovariectomized rats with established osteopenia.
Shen V; Dempster DW; Mellish RW; Birchman R; Horbert W; Lindsay R
Calcif Tissue Int; 1992 Mar; 50(3):214-20. PubMed ID: 1617495
[TBL] [Abstract][Full Text] [Related]
15. Skeletal response of ovariectomized rats to low and high doses of 17 beta-estradiol.
Kalu DN; Liu CC; Salerno E; Hollis B; Echon R; Ray M
Bone Miner; 1991 Sep; 14(3):175-87. PubMed ID: 1932891
[TBL] [Abstract][Full Text] [Related]
16. Continuous parathyroid hormone and estrogen administration increases vertebral cancellous bone volume and cortical width in the estrogen-deficient rat.
Zhou H; Shen V; Dempster DW; Lindsay R
J Bone Miner Res; 2001 Jul; 16(7):1300-7. PubMed ID: 11450706
[TBL] [Abstract][Full Text] [Related]
17. Short- and long-term effects of calcium and exercise on bone mineral density in ovariectomized rats.
Gala J; Díaz-Curiel M; de la Piedra C; Calero J
Br J Nutr; 2001 Oct; 86(4):521-7. PubMed ID: 11591240
[TBL] [Abstract][Full Text] [Related]
18. Human parathyroid hormone-(1-34) increases bone mass in ovariectomized and orchidectomized rats.
Hock JM; Gera I; Fonseca J; Raisz LG
Endocrinology; 1988 Jun; 122(6):2899-904. PubMed ID: 3371266
[TBL] [Abstract][Full Text] [Related]
19. Skeletal efficacy with parathyroid hormone in rats was not entirely beneficial with long-term treatment.
Sato M; Ma YL; Hock JM; Westmore MS; Vahle J; Villanueva A; Turner CH
J Pharmacol Exp Ther; 2002 Jul; 302(1):304-13. PubMed ID: 12065731
[TBL] [Abstract][Full Text] [Related]
20. ED-71, a vitamin D analog, is a more potent inhibitor of bone resorption than alfacalcidol in an estrogen-deficient rat model of osteoporosis.
Uchiyama Y; Higuchi Y; Takeda S; Masaki T; Shira-Ishi A; Sato K; Kubodera N; Ikeda K; Ogata E
Bone; 2002 Apr; 30(4):582-8. PubMed ID: 11934649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
